AR088350A1 - Pasta, proceso de elaboracion y uso de la pasta - Google Patents

Pasta, proceso de elaboracion y uso de la pasta

Info

Publication number
AR088350A1
AR088350A1 ARP120103850A ARP120103850A AR088350A1 AR 088350 A1 AR088350 A1 AR 088350A1 AR P120103850 A ARP120103850 A AR P120103850A AR P120103850 A ARP120103850 A AR P120103850A AR 088350 A1 AR088350 A1 AR 088350A1
Authority
AR
Argentina
Prior art keywords
paste according
acids
steroidal anti
drug
pasta
Prior art date
Application number
ARP120103850A
Other languages
English (en)
Inventor
Wang Shouming
Dauvergne Jerome
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of AR088350A1 publication Critical patent/AR088350A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una pasta oral que comprende lo siguiente: (i) al menos una droga antiinflamatoria no esteroide, (ii) al menos un agente modificador de la viscosidad, (iii) un vehículo líquido. Reivindicación 2: Una pasta de acuerdo con la reivindicación 1, caracterizada porque la droga antiinflamatoria no esteroide se selecciona entre el grupo conformado por salicilatos, acetaminofeno, ácidos arilalcanoicos, ácidos 2-arilpropiónicos (profenos), ácidos N-arilantranílicos (ácidos fenámicos), oxicam, coxib, sulfonanilidas, drogas antiinflamatorias no esteroides que tienen propiedades inhibitorias tanto de la ciclooxigenasa (II) como de la lipooxigenasa -tales como tepoxalina- y mezclas de dos o más de ellos. Reivindicación 4: Una pasta de acuerdo con la reivindicación 3, caracterizada porque la droga antiinflamatoria no esteroide es meloxicam. Reivindicación 31: Una pasta de acuerdo con una cualquiera de las reivindicaciones anteriores, que comprende, además, al menos una droga adicional. Reivindicación 32: Una pasta de acuerdo con la reivindicación 31, caracterizada porque dicha droga adicional -al menos una- es un agente antimicrobiano, antibiótico, antiviral, anti-úlcera/anti-ácido o anti-cáncer, o una combinación de dos o más de ellos.
ARP120103850A 2011-10-17 2012-10-16 Pasta, proceso de elaboracion y uso de la pasta AR088350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1117858.9A GB201117858D0 (en) 2011-10-17 2011-10-17 Paste

Publications (1)

Publication Number Publication Date
AR088350A1 true AR088350A1 (es) 2014-05-28

Family

ID=45219794

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103850A AR088350A1 (es) 2011-10-17 2012-10-16 Pasta, proceso de elaboracion y uso de la pasta

Country Status (17)

Country Link
US (1) US20140287048A1 (es)
EP (1) EP2768478B1 (es)
AR (1) AR088350A1 (es)
AU (1) AU2012324605B2 (es)
CA (1) CA2852613A1 (es)
CY (1) CY1124227T1 (es)
DK (1) DK2768478T3 (es)
ES (1) ES2869880T3 (es)
GB (1) GB201117858D0 (es)
HR (1) HRP20210807T1 (es)
HU (1) HUE055148T2 (es)
LT (1) LT2768478T (es)
PL (1) PL2768478T3 (es)
PT (1) PT2768478T (es)
RS (1) RS62048B1 (es)
SI (1) SI2768478T1 (es)
WO (1) WO2013057461A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014116221B4 (de) 2014-11-06 2019-05-23 Ferton Holding S.A. Überwachungssystem und Verfahren zur Überwachung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA987800B (en) * 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
KR100288190B1 (ko) * 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
EP0945131A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
US6924273B2 (en) * 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
JP2005533047A (ja) * 2001-06-07 2005-11-04 チョウ・コンサルティング・インコーポレイテッド アフタ潰瘍および単純ヘルペス病変の予防および処置のための組成物および方法
US7816366B2 (en) * 2002-02-12 2010-10-19 Asymmetric Therapeutics, Llc Compositions and methods for treating and preventing dermatoses
CA2499093A1 (en) * 2002-09-17 2004-04-01 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
US20050069590A1 (en) 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
EP1582221A1 (en) * 2004-03-31 2005-10-05 Chiesi S.A. Pharmaceutical oral compositions with a taste masking effect
PL1824493T3 (pl) 2004-12-06 2009-01-30 Janssen Pharmaceutica Nv Zawiesina zawierająca meloksykam do podawania doustnego
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2763456C (en) * 2009-05-27 2017-10-24 Alkermes Pharma Ireland Limited Reduction of flake-like aggregation in nanoparticulate active agent compositions

Also Published As

Publication number Publication date
PL2768478T3 (pl) 2021-10-04
AU2012324605B2 (en) 2017-02-23
SI2768478T1 (sl) 2021-09-30
ES2869880T3 (es) 2021-10-26
NZ624222A (en) 2016-01-29
GB201117858D0 (en) 2011-11-30
HUE055148T2 (hu) 2021-11-29
DK2768478T3 (da) 2021-05-25
EP2768478B1 (en) 2021-03-17
WO2013057461A1 (en) 2013-04-25
PT2768478T (pt) 2021-05-27
AU2012324605A1 (en) 2014-05-29
US20140287048A1 (en) 2014-09-25
EP2768478A1 (en) 2014-08-27
LT2768478T (lt) 2021-07-12
HRP20210807T1 (hr) 2021-06-25
CA2852613A1 (en) 2013-04-25
CY1124227T1 (el) 2022-05-27
RS62048B1 (sr) 2021-07-30

Similar Documents

Publication Publication Date Title
CL2019000510A1 (es) Adenovirus armado con un activador de células t biespecífico (bite).
CO2017001035A2 (es) “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios
CL2015001864A1 (es) Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih.
CL2016002414A1 (es) Compuestos derivados de nucleosidos, inhibidores de la transcriptasa inversas composición farmacéutica que los comprende y su uso en el tratamiento de una infección por vih. pct
CL2015003117A1 (es) Modificaciones en la estructura cristalina
CL2013001339A1 (es) Compuestos derivados heterociclicos condensados, con actividad antiviral; composicion farmaceutica que los comprende; y su uso para la prevencion o tratamiento de la infeccion de vih.
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
CL2011002878A1 (es) Compuestos derivados de tieno[2,3-b]piridinas, inhibidores de la replicacion del virus vih; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para prevenir o tratar una infeccion por vih.
CL2013003019A1 (es) Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih.
CU20140068A7 (es) Triazolopiridinas sustituidas
CL2012003421A1 (es) Compuestos derivados de 3-amino-n-(4-carbamoilpiridin-3-il)(aril/heteroaril)-2-carboxamida; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad del snc, oncologica, entre otras. pct fase nacional
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
ECSP13012569A (es) Formulación de premezcla de dexmedetomidina
ECSP099581A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
DOP2016000253A (es) Nuevos compuestos
CL2016000008A1 (es) Tratamiento de lesiones inflamatorias de rosacea con ivermectina.
CU20120171A7 (es) Triazolopiridinas sustituidas
UY35293A (es) Isotiazoles sustituidos con amino
CL2012003038A1 (es) Polietilenglicol conjugado a factor viia; composicion farmacéutica que comprende dicho polietilenglicol conjugado a factor viia; uso de una composicion farmaceutica para tratar enfermedad o trauma de la coagulacion de la sangre en un paciente que la necesita; proceso para preparar el siguiente polietilenglicol conjugado a factor viia.
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
DOP2016000007A (es) Pirazolpiridinas sustituidas
UY34008A (es) ?formas en estado sólido de inhibidor de hiv, composición farmacéutica, uso de la misma, y procesos para preparar dichas formas?.
UY35344A (es) Oestra-1,3,5(10),16-tetraeno-3-carboxamidas
UY35848A (es) Tienopirimidinas
BR112016022722B8 (pt) Composto, composição farmacêutica que o comprende e uso do mesmo

Legal Events

Date Code Title Description
FB Suspension of granting procedure